The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Senter L, Hovick S, Notestine R, Norden L, Benny N, Phillips S, Willoughby A, Pyatt R, Agnese D, Mak JS, DePersia A, Colonna SV, Maxwell WF, Kohlmann W, Spaeth EL, Gordon O, Thull D, Brock GN, Webb A, Smith RM, Toland AE

Open source

DOI: 10.1158/1940-6207.capr-26-0044
Published: 2026 Sep 1
Container: Cancer prevention research (Philadelphia, Pa.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1940-6207.capr-26-0044,
  title = {The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.},
  author = {Senter L and Hovick S and Notestine R and Norden L and Benny N and Phillips S and Willoughby A and Pyatt R and Agnese D and Mak JS and DePersia A and Colonna SV and Maxwell WF and Kohlmann W and Spaeth EL and Gordon O and Thull D and Brock GN and Webb A and Smith RM and Toland AE},
  year = {2026},
  journal = {Cancer prevention research (Philadelphia, Pa.)},
  doi = {10.1158/1940-6207.capr-26-0044},
  url = {https://doi.org/10.1158/1940-6207.capr-26-0044}
}

RIS

TY  - JOUR
TI  - The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.
AU  - Senter L
AU  - Hovick S
AU  - Notestine R
AU  - Norden L
AU  - Benny N
AU  - Phillips S
AU  - Willoughby A
AU  - Pyatt R
AU  - Agnese D
AU  - Mak JS
AU  - DePersia A
AU  - Colonna SV
AU  - Maxwell WF
AU  - Kohlmann W
AU  - Spaeth EL
AU  - Gordon O
AU  - Thull D
AU  - Brock GN
AU  - Webb A
AU  - Smith RM
AU  - Toland AE
PY  - 2026
JO  - Cancer prevention research (Philadelphia, Pa.)
DO  - 10.1158/1940-6207.capr-26-0044
UR  - https://doi.org/10.1158/1940-6207.capr-26-0044
ER  -

APA

L, S., S, H., R, N., L, N., N, B., S, P., A, W., R, P., D, A., JS, M., A, D., SV, C., WF, M., W, K., EL, S., O, G., D, T., GN, B., A, W., RM, S., & AE, T. (2026). The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.. Cancer prevention research (Philadelphia, Pa.). https://doi.org/10.1158/1940-6207.capr-26-0044

Source records

pubmed · retrieved 2026-09-26T08:22:47.042Z